NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,122 filers reported holding NOVARTIS A G in Q1 2022. The put-call ratio across all filers is 0.55 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $295,201 | -8.9% | 3,254 | -23.5% | 0.16% | +42.5% |
Q3 2022 | $324,000 | +32.8% | 4,253 | +47.2% | 0.11% | -26.6% |
Q2 2022 | $244,000 | -2.0% | 2,889 | +1.4% | 0.15% | +14.9% |
Q1 2022 | $249,000 | -13.2% | 2,848 | -13.3% | 0.13% | -5.0% |
Q4 2021 | $287,000 | +1.4% | 3,286 | -5.1% | 0.14% | -8.4% |
Q3 2021 | $283,000 | -34.9% | 3,463 | -27.5% | 0.15% | +17.6% |
Q2 2021 | $435,000 | -8.8% | 4,775 | -14.5% | 0.13% | -15.5% |
Q1 2021 | $477,000 | -8.1% | 5,584 | +1.4% | 0.16% | -54.4% |
Q4 2020 | $519,000 | -16.3% | 5,506 | -22.8% | 0.34% | +32.8% |
Q3 2020 | $620,000 | +32.5% | 7,133 | +33.9% | 0.26% | -38.5% |
Q2 2020 | $468,000 | -5.3% | 5,328 | -11.3% | 0.42% | -24.8% |
Q1 2020 | $494,000 | -10.8% | 6,004 | +2.8% | 0.55% | +14.5% |
Q4 2019 | $554,000 | +12.1% | 5,840 | +2.7% | 0.48% | +1.0% |
Q3 2019 | $494,000 | -39.2% | 5,688 | -36.0% | 0.48% | -37.8% |
Q2 2019 | $812,000 | -53.4% | 8,890 | -50.9% | 0.77% | -10.5% |
Q1 2019 | $1,742,000 | +131.6% | 18,090 | +105.8% | 0.86% | -4.0% |
Q4 2018 | $752,000 | – | 8,790 | – | 0.90% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
PRENTISS SMITH & CO INC | 127,510 | $11,721,000 | 6.50% |
MANAGED ASSET PORTFOLIOS, LLC | 127,716 | $11,740,000 | 6.04% |
EXENCIAL WEALTH ADVISORS, LLC | 116,917 | $10,747,000 | 5.25% |
MCDANIEL TERRY & CO | 181,095 | $16,646,000 | 4.64% |
Fayerweather Charles | 18,180 | $1,671,000 | 4.54% |
Osher Van de Voorde Investment Management | 78,138 | $7,182,000 | 4.38% |
BROWN BROTHERS HARRIMAN & CO | 9,291,495 | $854,074,000 | 4.35% |
Boulegeris Investments, Inc. | 61,322 | $5,637,000 | 4.31% |
DODGE & COX | 45,723,035 | $4,202,861,000 | 4.23% |
WHV Investments, Inc. | 1,603,476 | $152,945,000 | 4.23% |